Body clock makeover: new study aims to tame blood sugar in seniors
NCT ID NCT07203196
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized lifestyle plan focused on improving diet, exercise, and sleep according to the body's natural rhythms can lower blood sugar levels in older adults. Sixteen participants aged 50-80 with elevated blood sugar and a long daily eating window will follow the plan for 2 months. The goal is to see if supporting biological rhythms can improve blood sugar control and overall health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 16 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age: 50-80 years 2. Fasting glucose ≥ 100 mg/dL or HbA1c \> 5.6% 3. Own a smartphone (Apple iOS or Android OS) 4. Proficient in reading and speaking in English 5. An eating window ≥12 hour/day 6. Willing to travel to sports facilities for exercise training sessions 7. Participants on cardiovascular medications (HMG CoA reductase inhibitors (statins), metformin, SLGT2 inhibitors, GLP1 receptor agonists other lipid-modifying drugs (including over-the counter drugs such as red yeast rice and fish oil), anti-hypertensive, drugs), are allowed if on a stable dose for 6-months, but dose adjustments are not allowed during the study Exclusion Criteria: 1. Insufficient dietary logging on the mCC app during screening, defined as less than 7 of 14 days of baseline of dietary logging with a minimum of 2 items a day, at least 5 hours apart 2. Type 1 Diabetes or Insulin-dependent Type 2 Diabetes 3. HbA1C \> 9.0% 4. Use of sulfonylurea or insulin within the last 3 months (due to unknown safety with TRE) 5. Change in medications that could impact study outcomes within the past 6 months 6. Change in weight of \>4kg in the past 3 months 7. Systolic BP greater than 160 mmHg and/or diastolic BP greater than 110 mmHg at rest 8. Fasting LDL cholesterol greater than 250 mg/dL 9. Fasting triglycerides greater than 500g/dL 10. Variable work hours, such as working night shifts 11. Caregiver for a dependent requiring frequent nocturnal care/sleep interruptions 12. Active tobacco use, illicit drug use, or history of treatment for alcohol abuse in the past 5 years. 13. Travel involving a time zone change of more than 3 hours twice or more during the study period 14. Active treatment for inflammatory and/or rheumatologic disease 15. History of a major adverse cardiovascular event within the past year (acute coronary syndrome, percutaneous coronary intervention, coronary artery bypass graft surgery, hospitalization for congestive heart failure, stroke/transient ischemic attack) 16. Uncontrolled arrhythmia (i.e. rate-controlled atrial fibrillation/atrial flutter are acceptable) 17. Previously diagnosed with sever aortic stenosis 18. Previously diagnosed with sever COPD (FEV1/FVC ratio \<.7 \& FEV1 (%predicted) \<49 19. Orthopedic impairments severely compromising exercise performance 20. BMI \<18.5 kg/m2 21. History of thyroid disease requiring dose titration of thyroid replacement medication(s) within the past 6 months (i.e. hypothyroidism on a stable dose of thyroid replacement therapy is not an exclusion). 22. History of adrenal disease in the past 5 years 23. History of malignancy undergoing active treatment, except non-melanoma skin cancer, in the past 5 years 24. History of an eating disorder in the past 5 years 25. History of cirrhosis in the past 5 years 26. History of stage 4 or 5 chronic kidney disease or dialysis in the past 5 years 27. History of HIV/AIDs 28. Currently enrolled in weight-loss or weight-management program 29. Regularly engages in 100 minutes or more of structured exercise 30. VO2 max threshold is above average for that individuals age group \[78\] 31. Uncontrolled psychiatric disorder including prior hospitalization
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aging, healthy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California San Diego
La Jolla, California, 92037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Very-Low-Carb diet reverse prediabetes? trial puts it to the test
- Heartbeat test aims to catch hidden nerve damage in diabetes
- Can four minutes of hard exercise match a longer workout for blood sugar?
- Can a Plant-Based diet program help patients lose weight and improve heart health?
- Can a health coach in your patient portal help you lose weight?
- Glucose sensor may flag diabetes risk in cystic fibrosis